Skip to main content

Table 1 Numbers of cases of monotherapy with DPP-4 inhibitors

From: Comparative effect of dipeptidyl-peptidase 4 inhibitors on laboratory parameters in patients with diabetes mellitus

Generic nameTrade nameDose (daily)Number of cases of monotherapy
SitagliptinJauvia®, Glactive®50 mg879
VildagliptinEqua®100 mg253
TeneligliptinTenelia®20 mg260
AlogliptinNesina®25 mg237
LinagliptinTrasenta®5 mg180
  1. DPP-4 dipeptidyl-peptidase 4